Synthesis and biological evaluation of bis and monocarbonate prodrugs of 10-hydroxycamptothecins

被引:57
作者
He, XG
Lu, W
Jiang, XQ
Cai, JC
Zhang, XW
Ding, J
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, SIBS, Shanghai 201203, Peoples R China
[2] Nanjing Univ, Jiangsu Prov Lab Nanotechnol, Nanjing 210093, Peoples R China
关键词
camptothecin; 10-hydroxycamptothecin; carbonate; anti-tumor;
D O I
10.1016/j.bmc.2004.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
In an effort to improve the stability of labile lactone ring of camptothecins, the his and mono-alkyl carbonate prodrugs of 10-hydroxycamptothecins were synthesized and their chemical and enzymatical stability as well as antitumor activity were studied. The in vitro evaluation of the stability of these carbonates indicates that the 10,20-biscarbonates are firstly hydrolyzed to afford the stable 20-monocarbonates. And the 10-carbonates are not stable in human plasma, mouse plasma and pH 7.4 phosphate buffer, while the 20-carbonates are relatively stable in the three media and can be readily cleaved by porcine liver esterase. The overall toxicity of the tested carbonate against mice bearing S 180 sarcoma is much lower when compared with the parent compound, and the antitumor activity is maintained. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4003 / 4008
页数:6
相关论文
共 16 条
[1]
CAI JC, 1982, ALKALOIDS CHEM PHARM, V21, P101
[2]
CAO CJ, 1989, CHEM PHARM BULL, V37, P2976
[3]
Alkyl esters of camptothecin and 9-nitrocamptothecin: Synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity [J].
Cao, ZS ;
Harris, N ;
Kozielski, A ;
Vardeman, D ;
Stehlin, JS ;
Giovanella, B .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (01) :31-37
[4]
Dallavalle S, 2002, EXPERT OPIN THER PAT, V12, P837
[5]
FORTUNAK JM, 1992, Patent No. 9205785
[6]
GIOVANELLA BC, 1991, CANCER RES, V51, P3052
[7]
HSIANG YH, 1985, J BIOL CHEM, V260, P4873
[8]
Milestones in camptothecin research [J].
Lerchen, HG .
DRUGS OF THE FUTURE, 2002, 27 (09) :869-878
[9]
MOERTEL CG, 1972, CANCER CHEMOTH REP 1, V56, P95
[10]
SAWADA S, 1991, CHEM PHARM BULL, V39, P1446